 Serum apolipoproteins low density lipoprotein subfractions fibrate treatment primary hypertriglyceridaemia Serum apolipoproteins hypertriglyceridaemic HTG patients period treatment gemfibrozil washout period marked decrease low density lipoprotein VLDL cholesterol triglyceride increase high density lipoprotein HDL cholesterol component slight increase low density lipoprotein LDL cholesterol weeks weeks treatment increase serum apolipoprotein A-II levels reduction serum apo C-III VLDL subfractionation density gradient centrifugation subfractions size predominant reduction large subfractions decrease VLDL-D marked Percentage changes baseline level VLDL-A VLDL-D cholesterol percentage changes HDL LDL cholesterol transfer cholesterol VLDL-A HDL VLDL-D LDL data fibrate-induced stimulation lipoprotein lipase enhanced transfer cholesterol VLDL LDL fibrates HTG patients pronounced prolonged period treatment